Figure 1
Increased frequency of Th17 cells in freshly isolated mononuclear cells in myeloma. (A) Mononuclear cells were isolated from multiple myeloma (MM) patients (blood, N = 11, bone marrow [BM], N = 4) and from healthy donors (HDs; blood, N = 12; BM, N = 3) and stimulated for 6 hours with PMA and ionomycin and stained for intracellular interleukin-17 (IL-17) and interferon-γ (IFN-γ). Proportion of IL-17–producing Th17 cells was determined in CD4 population by flow cytometry. A representative dot plot analysis showing percentage of cells that are positive for intracellular IL-17 and IFN-γ within gated CD4 population using matching peripheral blood and BM samples from MM and HDs is shown. (B) Composite results presented as mean value with SEM for Th17 with in CD4 population. (C) RNA was isolated from CD4 cells from MM patients (N = 3) and healthy donors (N = 3) using QIAGEN kits and quantitative PCR was performed. *P < .05.

Increased frequency of Th17 cells in freshly isolated mononuclear cells in myeloma. (A) Mononuclear cells were isolated from multiple myeloma (MM) patients (blood, N = 11, bone marrow [BM], N = 4) and from healthy donors (HDs; blood, N = 12; BM, N = 3) and stimulated for 6 hours with PMA and ionomycin and stained for intracellular interleukin-17 (IL-17) and interferon-γ (IFN-γ). Proportion of IL-17–producing Th17 cells was determined in CD4 population by flow cytometry. A representative dot plot analysis showing percentage of cells that are positive for intracellular IL-17 and IFN-γ within gated CD4 population using matching peripheral blood and BM samples from MM and HDs is shown. (B) Composite results presented as mean value with SEM for Th17 with in CD4 population. (C) RNA was isolated from CD4 cells from MM patients (N = 3) and healthy donors (N = 3) using QIAGEN kits and quantitative PCR was performed. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal